The agency has given a positive recommendation for a change in the gas propellant in Trixeo Aerosphere and Riltrava ...

The new inhaler replaces Trixeo Aerosphere’s existing gas propellant with a low global warming-potential alternative.

European regulators have given their backing to a new eco-friendly inhaler that could help curb health care’s climate impact.

Microsoft and our third-party vendors use cookies to store and access information such as unique IDs to deliver, maintain and ...

Urine VOCs are linked to COPD risk and inflammation in NHANES data, suggesting potential for non-invasive screening with ...

Topline data were announced from two phase 3 trials evaluating astegolimab in patients with moderate to very severe COPD.

Roche’s hopes of getting its chronic obstructive pulmonary disease (COPD) drug astegolimab to regulators this year have taken ...

Chronic obstructive pulmonary disease causes 2.5 times more deaths in men than in women. From 2001 to 2019, mortality due to that pathology declined by 43% in men and women.

For patients with chronic obstructive pulmonary disease (COPD), budesonide-glycopyrrolate-formoterol does not improve clinical outcomes compared with fluticasone-umeclidinium-vilanterol, according ...

Chronic obstructive pulmonary disease (COPD) is a genetically and environmentally determined disease characterized by airflow limitation that is not fully reversible (reviewed by Barnes). 1 The ...